| Group A (n = 29) | Group B (n = 56) | P value |
---|---|---|---|
Background factors | |||
Age (year)a | 78 (41–95) | 75 (23–92) | 0.363 |
Gender (female/male) | 14/15 | 21/35 | 0.362 |
Type (EAMI/TAMI/NOMI/VAMI) | 4/10/15/0 | 14/17/20/5 | 0.171 |
Medical history | |||
Recent cardiovascular procedureb (n) | 7 | 12 | 0.789 |
Coronary artery disease (n) | 9 | 24 | 0.352 |
Cerebral vascular event (n) | 5 | 11 | 1.000 |
Chronic lung disease (n) | 5 | 6 | 0.499 |
Essential hypertension (n) | 18 | 43 | 0.204 |
Dyslipidemia (n) | 3 | 3 | 0.406 |
Liver cirrhosis (n) | 2 | 4 | 1.000 |
Atrial fibrillation (n) | 4 | 8 | 1.000 |
Diabetes mellitus (n) | 14 | 20 | 0.351 |
Dialysis (n) | 11 | 10 | 0.062 |
Regular antiplatelet or anticoagulant use (n) | 10 | 23 | 0.642 |
Preoperative factors | |||
WBC count(/uL) | 15,400 (3,250–37,700) | 11,685 (890–28,800) | 0.031 |
WBC count out of normal rangec (n) | 20 | 28 | 0.111 |
Positive band form of WBC (n) | 21 | 26 | 0.037 |
NLR (%) | 12.7 (2.7–98.0) | 13.0 (1.9–97.0) | 0.704 |
Platelet count (/uL) | 139,000 (14,000–485,000) | 145,500 (21,000–341,000) | 0.871 |
INR of PT | 1.17 (0.91–8.77) | 1.13 (0.88–3.50) | 0.226 |
Hemoglobin (g/dL) | 10.3 (6.1–14.8) | 11.9 (6.0–16.6) | 0.012 |
Serum albumin (g/dL) | 2.5 (1.2–4.5) | 3.1 (1.5–4.5) | 0.002 |
Serum ALT (U/L) | 28 (7–3049) | 30 (4–1332) | 0.714 |
Serum bilirubin (mg/dL) | 0.8 (0.2–6.4) | 0.9 (0.3–9.5) | 0.451 |
Serum creatinine (mg/dL) | 3.7 (0.9–12.0) | 2.5 (0.40–12.1) | 0.047 |
Shock status (n) | 14 | 15 | 0.057 |
Surgical factors | |||
Time to surgery (hour)d | 5.4 (2.14–102.7) | 5.5 (1.6–134.0) | 0.802 |
Intraoperative red blood transfusion (n) | 2 | 7 | 0.712 |
Combined colon resection (n) | 4 | 22 | 0.024 |
End-enterostomy (n) | 16 | 44 | 0.043 |
Functional residual small intestine (cm) | 170 (5–270) | 115 (10–400) | 0.820 |
Prognosis | Â | Â | Â |
30-days mortality (n) | 15 | 9 | 0.001 |
2-year survival rates (%) | 19 | 45.4 | 0.001 |